Patient Self-Management of Oral Anticoagulation

Letters21 June 2005Patient Self-Management of Oral AnticoagulationJuan Carlos Souto, MD, PhD, Bárbara Menéndez-Jándula, MD, and Jordi Fontcuberta, MD, PhDJuan Carlos Souto, MD, PhDFrom the Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.Search for more papers by this author, Bárbara Menéndez-Jándula, MDFrom the Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.Search for more papers by this author, and Jordi Fontcuberta, MD, PhDFrom the Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:The main purpose of our study was to evaluate the reliability of self-management (with all of its theoretical advantages, including ease for weekly testing at home) in comparison with the actual management of anticoagulant therapy in Spanish clinics. In most Spanish clinics, the number of patients each clinic sees makes weekly monitoring almost impossible. For example, in our clinic, we monitor more than 6000 patients each month. Maybe the ideal design of our study would have included the same interval between tests in both arms, but in our opinion the results would not have been applicable to real-life ...References1. Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost. 2000;83:698-703. [PMID: 10823265] CrossrefMedlineGoogle Scholar2. Beyth RJ. Patient self-management of anticoagulation: an idea whose time has come [Editorial]. Ann Intern Med. 2005;142:73-4. [PMID: 15630111] LinkGoogle Scholar3. Olsson SB. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet. 2003;362:1691-8. [PMID: 14643116] CrossrefMedlineGoogle Scholar4. Koertke H, Minami K, Boethig D, Breymann T, Seifert D, Wagner O, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation. 2003;108 Suppl 1 II75-8. [PMID: 12970212] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Juan Carlos Souto, MD, PhD; Bárbara Menéndez-Jándula, MD; Jordi Fontcuberta, MD, PhDAffiliations: From the Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoComparing Self-Management of Oral Anticoagulant Therapy with Clinic Management Bárbara Menéndez-Jándula , Juan Carlos Souto , Arturo Oliver , Isabel Montserrat , Mireia Quintana , Ignasi Gich , Xavier Bonfill , and Jordi Fontcuberta Patient Self-Management of Anticoagulation: An Idea Whose Time Has Come Rebecca J. Beyth Patient Self-Management of Oral Anticoagulation Benton M. Wheeler III Patient Self-Management of Oral Anticoagulation Benton M. Wheeler III Metrics 21 June 2005Volume 142, Issue 12_Part_1Page: 1023KeywordsClinical trialsHealth care providersHemorrhagePilot studiesResearch laboratoriesSafetySafety studiesThrombin ePublished: 21 June 2005 Issue Published: 21 June 2005 Copyright & PermissionsCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...